Aortopathy in young MFS mice is worsened by loss of SMC TBRII. A through C, Representative sections of ascending aortas of 8‐week‐old mice, 2 weeks after treatment with tamoxifen. Sections are from (A) an Acta2‐Cre0/0
Fbn1
+/+ mouse (WT), (B) an Acta2‐Cre0/0
Fbn1
C1039G/+ mouse [MFS(T)]; or (C) an Acta2‐Cre+/0
Fbn1
C1039G/+ mouse (MFS‐TBRII
−/−). All mice were Tgfbr2
flox/flox. A through C, Scale bar: 100 μm. D and E, Measurements made on sections of ascending aorta of groups in A through C. D, Length of internal elastic lamina (IEL); (E) length of external elastic lamina (EEL); (F) medial elastin damage was quantified by counting elastin breaks on sections of ascending aorta of groups in A through C. G, Aortic medial degeneration was graded with an aortic wall architecture score. D through G, Data are mean±SEM; n=7 to 8 per group; t tests with Bonferroni correction; *P<0.05; ***P<0.001. MFS indicates Marfan syndrome; SMC, smooth muscle cells; (T), tamoxifen; TBRII, type II TGF‐β receptor; WT, wild‐type.